Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Zendy

Elifcan Aladağ | Zendy; Halûk Demiroğlu | Zendy; Ümi̇t Yavuz Malkan | Zendy; Ümit Akman | Zendy; Hakan Göker | Zendy; Yahya Büyükaşık | Zendy

Open Access

Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Author(s) -

Elifcan Aladağ,

Halûk Demiroğlu,

Ümi̇t Yavuz Malkan,

Ümit Akman,

Hakan Göker,

Yahya Büyükaşık

Publication year - 2020

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2007-17

Subject(s) - medicine , hematopoietic stem cell transplantation , stem cell , transplantation , haematopoiesis , biomarker , graft versus host disease , immunology , disease , gastroenterology , complication , population , biology , biochemistry , genetics , environmental health

Graft-versus-host disease (GVHD) is a crucial complication leading to significant morbidity and mortality allogeneic hematopoietic stem cell transplantation which occurs in approximately half of the transplant recipients. Suppression of tumorigenicity 2 (ST2) and regenerating islet-derived 3-alpha(Reg3a) might be important biomarkers to predict acute GVHD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research